LSL Web-Exclusive Content

  1. Krystal Biotech’s Side Business: Gene-Based Aesthetics 11/1/2023

    Krystal Biotech's side business is an aesthetics company, Jeune Aesthetics, that uses the same platform and viral vector as Krystal to deliver collagen genes to consumers seeking aesthetic improvement.

  2. The New Economics Of Cell And Gene Therapy 10/5/2023

    The authors explain why we are seeing more withdrawals than blockbusters and what we should do about it.

  3. Here’s Why Outsourcing To CDMOs Doubled In 13 Years 10/4/2023

    It might surprise no one that BioPlan Associates' 20th annual survey on manufacturing found an increased dependence on contract manufacturing. The sheer rate at which demand has grown, however, is stunning, and the survey found CDMO capacity is only now starting to catch up with supply.

  4. FDA Announces 1-Year “Stabilization” Period For DSCSA Compliance — Don’t Mistake It For An Enforcement Delay 10/4/2023

    On August 30 in a new guidance document, the FDA announced the establishment of a one-year stabilization period with regard to the enhanced security and unit-level electronic traceability requirements of the Drug Supply Chain Security Act (DSCSA) that go into effect on Nov. 27, 2023. The FDA makes it clear that this is not an opportunity to delay implementation; rather, it is an opportunity to refine, improve, and stabilize your systems and processes.

  5. A 6-Point Business Framework For Scaling Up Your Cell Therapy Startup 10/2/2023

    Investors see many risks associated with investing in startups. If your cell and gene therapy company is planning to scale, you need to be careful about capital allocation, intellectual property nuances specific to the space, and more.

  6. 7 Improvements in Clinical Supply Chain Management Your CFO Will Love 10/2/2023

    There is a great opportunity for clinical supply chain practitioners to learn from their commercial peers. By adapting and adopting the right commercial best practices, clinical supply chains become more effective, cost-efficient, and agile in delivering the right treatments to the right patients.

  7. The One Soft Skill That Many CRPs Are Missing 9/29/2023

    Employee burnout appears rampant across industries, and clinical research is not immune. So, what's a pharma, CRO, or site to do? Aga Finlayson of White Wisteria Academy has an idea: honing one specific clinical research professional soft skill to the benefit of employers and employees alike.

  8. Unleashing Team Potential: The Power Of Emotional Intelligence In Leadership 9/27/2023

    Emotional intelligence refers to an individual’s ability to “recognize, use, understand, and manage their emotions in a positive way,” explains PsychCentral. While expressing and controlling one’s own emotions is imperative as an executive, so is the ability to understand, interpret, and respond to the emotions of others.

  9. Why Royalty Financing Is A Smart Funding Alternative For Small Life Science Companies 9/27/2023

    Royalty financing has emerged as an attractive solution to secure funding in the current challenging fundraising environment, offering a range of advantages tailored to the unique characteristics of small life science companies, from preserving ownership and intellectual property control to providing accessible funding for high-risk ventures.

  10. How To Lose A Batch In 10 Days 9/25/2023

    Inspired by the rom com How to Lose a Guy in 10 Days, this article spotlights the critical missteps that could lead you to lose a batch during the manufacturing process. By identifying these pitfalls, the author guides you toward best practices that will not only save your batches but also improve the quality, efficiency, and reliability of your operations.